Highlights d Novel LC-MS-based methods enable personalized IgG1 profiling in plasma d Each donor exhibits a simple but unique serological IgG1 repertoire d This repertoire adapts to changes in physiology, e.g., sepsis d Individual plasma IgG1 clones can be identified by combining top-down and bottom-up proteomics
Antibody sequence
information is crucial to understanding the structural
basis for antigen binding and enables the use of antibodies as therapeutics
and research tools. Here, we demonstrate a method for direct de novo sequencing of monoclonal IgG from the purified antibody
products. The method uses a panel of multiple complementary proteases
to generate suitable peptides for de novo sequencing
by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a
bottom-up fashion. Furthermore, we apply a dual fragmentation scheme,
using both stepped high-energy collision dissociation (stepped HCD)
and electron-transfer high-energy collision dissociation (EThcD),
on all peptide precursors. The method achieves full sequence coverage
of the monoclonal antibody herceptin, with an accuracy of 99% in the
variable regions. We applied the method to sequence the widely used
anti-FLAG-M2 mouse monoclonal antibody, which we successfully validated
by remodeling a high-resolution crystal structure of the Fab and demonstrating
binding to a FLAG-tagged target protein in Western blot analysis.
The method thus offers robust and reliable sequences of monoclonal
antibodies.
The continued threat of SARS-CoV-2 to global health necessitates development of improved research tools and vaccines. We present an improved SARS-CoV-2 spike ectodomain, 'VFLIP', bearing five proline substitutions, a flexible cleavage site linker, and an inter-protomer disulfide bond. VFLIP displays significantly improved stability, high-yield production and retains its trimeric state without exogenous trimerization motifs. High-resolution cryo-EM and glycan profiling reveal that the VFLIP quaternary structure and glycosylation mimic the native spike on the viral surface. Further, VFLIP has enhanced affinity and binding kinetics relative to other stabilized spike proteins for antibodies in the Coronavirus Immunotherapeutic Consortium (CoVIC), and mice immunized with VFLIP exhibit potent neutralizing antibody responses against wild-type and B.1.351 live SARS-CoV-2. Taken together, VFLIP represents an improved tool for diagnostics, structural biology, antibody discovery, and vaccine design.
Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell disorder characterized by the presence of a predominant monoclonal antibody (i.e., M-protein) in serum, without clinical symptoms. Here we present a case study in which we detect MGUS by liquid-chromatography coupled with mass spectrometry (LC-MS) profiling of IgG1 in human serum. We detected a Fab-glycosylated M-protein and determined the full heavy and light chain sequences by bottom-up proteomics techniques using multiple proteases, further validated by top-down LC-MS. Moreover, the composition and location of the Fab-glycan could be determined in CDR1 of the heavy chain. The outlined approach adds to an expanding mass spectrometry-based toolkit to characterize monoclonal gammopathies such as MGUS and multiple myeloma, with fine molecular detail. The ability to detect monoclonal gammopathies and determine M-protein sequences straight from blood samples by mass spectrometry provides new opportunities to understand the molecular mechanisms of such diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.